Meng et al. (2020) found that JSD (0.5 g/kg/d) was able to restore the intestinal flora composition of STZ-induced DKD mice, which in turn participated in the metabolic disorders and chronic inflammation of DKD, manifested by the reduction of fasting glucose, triglycerides, urinary albumin, and the reduction of renal tissue damage. The modified microbiota includes Alphaproteobacteri, Atopobiaceaem, Acetatifactor, Butyricicoccus, Ker-stersia, Peptococcus, and Coriobacteraceae_UCG-002. The gene discussed is ALB; the disease is diabetic kidney disease.